Self administered therapy (SAT)

BEHAVIORAL2 trials

Sponsors

Centers for Disease Control and Prevention

Conditions

HIV/AIDSLatent Tuberculosis Infection

Phase 3

Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT

CompletedNCT01582711

Centers for Disease Control and PreventionLatent Tuberculosis Infection

Start: 2012-09-30End: 2014-10-31Updated: 2025-03-13

Unknown Phase

Aetiology of treatment failure in HIV positive children and adolescents on boosted protease inhibitor based regimens.

RecruitingPACTR201502001028169

Start: 2014-07-01Target: 130Updated: 2026-09-14

Related Papers

Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection

Clinical Infectious Diseases2023-02-2315 citations

Exposure to Latent Tuberculosis Treatment during Pregnancy. The PREVENT TB and the iAdhere Trials

Annals of the American Thoracic Society2018-02-0258 citations

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial.

2017-11-07117 citations